Christopher Patusky - Net Worth and Insider Trading
Christopher Patusky Net Worth
The estimated net worth of Christopher Patusky is at least $258,170 dollars as of 2024-04-28. Christopher Patusky is the Director of United Therapeutics Corp and owns about 1,104 shares of United Therapeutics Corp (UTHR) stock worth over $258,170. Details can be seen in Christopher Patusky's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Christopher Patusky has not made any transactions after 2024-02-23 and currently still holds the listed stock(s).
Transaction Summary of Christopher Patusky
Christopher Patusky Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Christopher Patusky owns 1 companies in total, including United Therapeutics Corp (UTHR) .
Click here to see the complete history of Christopher Patusky’s form 4 insider trades.
Insider Ownership Summary of Christopher Patusky
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| UTHR | United Therapeutics Corp | 2024-02-23 | director |
Christopher Patusky Latest Holdings Summary
Christopher Patusky currently owns a total of 1 stock. Christopher Patusky owns 1,104 shares of United Therapeutics Corp (UTHR) as of February 23, 2024, with a value of $258,170.
Latest Holdings of Christopher Patusky
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| UTHR | United Therapeutics Corp | 2024-02-23 | 1,104 | 233.85 | 258,170 |
Holding Weightings of Christopher Patusky
Christopher Patusky Form 4 Trading Tracker
According to the SEC Form 4 filings, Christopher Patusky has made a total of 5 transactions in United Therapeutics Corp (UTHR) over the past 5 years, including 1 buys and 4 sells. The most-recent trade in United Therapeutics Corp is the sale of 1,680 shares on February 23, 2024, which brought Christopher Patusky around $376,320.
Insider Trading History of Christopher Patusky
- 1
Christopher Patusky Trading Performance
GuruFocus tracks the stock performance after each of Christopher Patusky's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Christopher Patusky is -1.21%. GuruFocus also compares Christopher Patusky's trading performance to market benchmark return within the same time period. The performance of stocks bought by Christopher Patusky within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Christopher Patusky's insider trading performs compared to the benchmark.
Performance of Christopher Patusky
Average Return
48.17%
Outperforming Transactions
100%
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -4.47 | -1.21 | 12.31 | 48.17 | 47.54 | 38.58 |
| Relative Return to S&P 500(%) | -8.15 | -4.42 | 3.8 | 37.69 | 26.39 | 28.03 |
Christopher Patusky Ownership Network
Ownership Network List of Christopher Patusky
Ownership Network Relation of Christopher Patusky
Christopher Patusky Owned Company Details
What does United Therapeutics Corp do?
Who are the key executives at United Therapeutics Corp?
Christopher Patusky is the director of United Therapeutics Corp. Other key executives at United Therapeutics Corp include director & Chief Executive Officer Martine A Rothblatt , EVP & General Counsel Paul A Mahon , and President and COO Michael Benkowitz .
United Therapeutics Corp (UTHR) Insider Trades Summary
Over the past 18 months, Christopher Patusky made 2 insider transaction in United Therapeutics Corp (UTHR) with a net sale of 1,780. Other recent insider transactions involving United Therapeutics Corp (UTHR) include a net sale of 1,325,285 shares made by Martine A Rothblatt , a net sale of 206,500 shares made by Paul A Mahon , and a net sale of 1,977 shares made by Nilda Mesa .
In summary, during the past 3 months, insiders sold 442,290 shares of United Therapeutics Corp (UTHR) in total and bought 0 shares, with a net sale of 442,290 shares. During the past 18 months, 1,562,002 shares of United Therapeutics Corp (UTHR) were sold and 0 shares were bought by its insiders, resulting in a net sale of 1,562,002 shares.
United Therapeutics Corp (UTHR)'s detailed insider trading history can be found in Insider Trading Tracker table.
United Therapeutics Corp Insider Transactions
Christopher Patusky Mailing Address
Above is the net worth, insider trading, and ownership report for Christopher Patusky. Currently GuruFocus does not have mailing address information for Christopher Patusky.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
